Inventor · disambiguated record
Isabel Najera
Also filed as: NAJERA ISABEL
8 granted patents·10 pending applications·599 citations·filing 2001–2020
90Inventor score
Top patents by PatentIndex Score
18 records- 0198US6784166B24′-substituted nucleoside derivatives as inhibitors of HCV RNA replication.SYNTEX LLC·Filed 2002·Granted Aug 31, 2004·251 cites·8 claims
- 0297US6660721B2Anti-HCV nucleoside derivativesHOFFMANN LA ROCHE·Filed 2002·Granted Dec 9, 2003·208 cites·3 claims
- 0395US7915232B24′-substituted nucleoside derivatives as inhibitors of HCV RNA replicationROCHE PALO ALTO LLC·Filed 2009·Granted Mar 29, 2011·26 cites·2 claims
- 0494US8071567B24′-substituted nucleoside derivatives as inhibitors of HCV RNA replicationDEVOS RENE ROBERT·Filed 2009·Granted Dec 6, 2011·51 cites·9 claims
- 0594US7608601B24′-Substituted nucleoside derivatives as inhibitors of HCV RNA replicationROCHE PALO ALTO LLC·Filed 2004·Granted Oct 27, 2009·53 cites·4 claims
- 0692US10596173B2Combination therapy of an HBV capsid assembly inhibitor and an interferonHOFFMANN LA ROCHE·Filed 2018·Granted Mar 24, 2020·10 cites·25 claims
- 0763US8648054B24′-substituted nucleoside derivatives as inhibitors of HCV RNA replicationROCHE PALO ALTO LLC·Filed 2013·Granted Feb 11, 2014·0 cites·2 claims
- 0856US2012034184A14'-substituted nucleoside derivatives as inhibitors of hcv rna replicationDEVOS RENE ROBERT·Filed 2011·Application pending·0 cites
- 0956US2020276198A1Combination therapy of an hbv capsid assembly inhibitor and an interferonHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1050US2004110718A1Anti-HCV nucleoside derivativesFiled 2003·Application pending·0 cites
- 1146US2008026952A1HCV replicon shuttle vectorsROCHE PALO ALTO LLC·Filed 2006·Application pending·0 cites
- 1245US2003008841A1Anti-HCV nucleoside derivativesFiled 2001·Application pending·0 cites
- 1344US10597380B2Pyridazinone-based broad spectrum anti-influenza inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted Mar 24, 2020·0 cites·42 claims
- 1443US2010068698A1Production of infectious hepatitis c virus particles in cell cultureMCCOWN MATTHEW F·Filed 2009·Application pending·0 cites
- 1543US2019275052A1Combination therapy of an hbv capsid assembly inhibitor and a nucleos(t)ide analogueHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 1641US2009004664A1HCV NS3 replicon shuttle vectorsROCHE PALO ALTO LLC·Filed 2008·Application pending·0 cites
- 1740US2011245328A1HCV NS5A Replicon Shuttle VectorsKANG HYUNSOON·Filed 2011·Application pending·0 cites
- 1839US2011053160A1Hcv ns3/4a replicon shuttle vectorsALI SAMIR·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Isabel Najera files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →